ORTHOFIX MEDICAL INC.

OFIX Healthcare Medical Devices

ORTHOFIX MEDICAL INC.’s revenue for fiscal 2025 (year ended December 2025) was $822.3 million, up 2.85% from fiscal 2024. In the quarter to June 2026, revenue grew 3.85%, EPS fell 8.33%, free cash flow fell 516.6% and total debt rose 34.4%, each against the same quarter a year earlier. Revenue growth for three consecutive years; insiders bought in the last twelve months.

9.38 0.21 −2.19%
Market cap
$390.6M
P/E
0.0×
Fwd P/E
−8.5×
Dividend yield
—
F-score
5/9
Altman Z
1.29
Beneish M
−3.19
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
0.00 0.00 0.00 0.00

+8 more quarters

P/S ratio
0.45 0.56 0.73 0.71
P/FCF ratio
0.00 0.00 0.00 0.00
P/Operating CF
(60.07) (26.35) 21.68 46.94
P/B ratio
0.87 1.07 1.33 1.32
EV/Sales
0.61 0.71 0.85 0.85
EV/EBITDA
26.35 38.57 380.93 135.49
EV/FCF
(16.93) (86.67) (193.86) (133.74)
Current Ratio
2.84 2.87 2.45 2.47
Net Debt/EBITDA
20.89 986.10 5.75 (43.01)
Debt/Equity
0.55 0.54 0.39 0.39
Earnings Yield
(16.85%) (13.16%) (15.44%) (20.70%)
Free Cash Flow Yield
(8.06%) (1.45%) (0.60%) (0.90%)
Free Cash Flow per Share
(0.46) (0.70) 0.42 0.06
Book value per Share
10.49 10.76 11.36 11.13
Free Cash Flow
(18.87) (28.27) 16.82 2.50
EV/EBIT
0.00 0.00 0.00 0.00
Other line items

Show all line items

Columns are period end dates